Ross E. Longley
Impact in
- Biotechnology top 0.5%
- Marine Sponges and Natural Products
- Pharmacology top 1%
- Microbial Natural Products and Biosynthesis
Papers in
-
- Marine Sponges and Natural Products 19
- Oncology 16
- Cancer Treatment and Pharmacology 14
- HER2/EGFR in Cancer Research 3
- Co-authors
- Sarath P. Gunasekera (19 shared papers)Malika Gunasekera (4 shared papers)Frank E. Koehn (5 shared papers)Shirley A. Pomponi (11 shared papers)Billy W. Day (2 shared papers)Ernest Hamel (2 shared papers)Richard Kowalski (2 shared papers)Gayle K. Schulte (1 shared paper)
- Journals
- Journal of Natural Products (16 papers)Cellular Immunology (3 papers)Cellular and Molecular Life Sciences (2 papers)Transplantation (2 papers)Pharmaceutical Biology (2 papers)
- Partner nations
- United StatesUnited Kingdom
In The Last Decade
Ross E. Longley
46 papers receiving 2.3k citations
Peers
Comparison fields: 5 of 90
- Biotechnology 819
- Pharmacology 724
- Organic Chemistry 1.1k
- Oncology 826
- Toxicology 102
Countries citing papers authored by Ross E. Longley
This map shows the geographic impact of Ross E. Longley's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ross E. Longley with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ross E. Longley more than expected).
Fields of papers citing papers by Ross E. Longley
This network shows the impact of papers produced by Ross E. Longley. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ross E. Longley. The network helps show where Ross E. Longley may publish in the future.
Co-authors
The 25 scholars most cited alongside Ross E. Longley, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1996 | 339 | |
| 2 | 1990 | 318 | |
| 3 | 1997 | 229 | |
| 4 | 1992 | 160 | |
| 5 | 2003 | 143 | |
| 6 | 1993 | 97 | |
| 7 | 1991 | 90 | |
| 8 | 1994 | 89 | |
| 9 | 1991 | 61 | |
| 10 | 2003 | 58 | |
| 11 | 1994 | 55 | |
| 12 | 1993 | 47 | |
| 13 | 2002 | 45 | |
| 14 | 1998 | 43 | |
| 15 | 1994 | 41 | |
| 16 | 1997 | 40 | |
| 17 | 1993 | 37 | |
| 18 | 1994 | 37 | |
| 19 | 1989 | 36 | |
| 20 | 2002 | 34 |
About Ross E. Longley
Ross E. Longley is a scholar working on Biotechnology, Oncology, Organic Chemistry, Cancer Research and Immunology, having authored 48 papers that have together received 2.4k indexed citations. Recurring topics across this work include Marine Sponges and Natural Products (19 papers), Synthetic Organic Chemistry Methods (15 papers), Cancer Treatment and Pharmacology (14 papers), Synthesis and Biological Activity (10 papers), Microbial Natural Products and Biosynthesis (8 papers), Hematopoietic Stem Cell Transplantation (4 papers), Microtubule and mitosis dynamics (3 papers) and HER2/EGFR in Cancer Research (3 papers). The work is most often cited by research in Biotechnology (819 citations), Pharmacology (724 citations), Organic Chemistry (1.1k citations), Oncology (826 citations) and Toxicology (102 citations). Ross E. Longley has collaborated with scholars based in United States and United Kingdom. Frequent co-authors include Sarath P. Gunasekera, Malika Gunasekera, Frank E. Koehn, Shirley A. Pomponi, Billy W. Day, Ernest Hamel, Richard Kowalski, Gayle K. Schulte, Oliver J. McConnell and Amy E. Wright. Their work appears in journals such as Journal of Natural Products, Cellular Immunology, Cellular and Molecular Life Sciences, Transplantation and Pharmaceutical Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.